+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Human Organoids Market by Product (Colorectal, Heart, Kidney), Usability (Customizable Products, Ready to Use Products), Application, End-User - Forecast 2024-2030

  • PDF Icon

    Report

  • 190 Pages
  • June 2024
  • Region: Global
  • 360iResearch™
  • ID: 5674551
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Human Organoids Market size was estimated at USD 594.84 million in 2023, USD 703.34 million in 2024, and is expected to grow at a CAGR of 19.94% to reachUSD 2.12 billion by 2030.

These organ-specific structures provide an advanced platform for modeling disease, personalized medicine, drug screening, and potentially organ replacement therapies. Their ability to mimic human physiological responses at a cellular level makes them valuable for research and medical innovation. The growing requirement for drug discovery and drug development activities and the specificity and human relevance of organoid models to significantly enhance the efficacy and safety evaluation in the early stages of drug development contribute to the need for human organoids. Organoids can be derived from patient-specific cells, offering significant opportunities in personalized therapy by tailoring treatments based on individual genetic makeup and disease pathology. The ability of human organoids to accurately model various diseases, including rare and genetic disorders, provides researchers with detailed insights into disease mechanisms, paving the way for novel therapeutic approaches. However, the complex protocols required to generate organoids can result in variations between batches, affecting the scalability and reproducibility of research outcomes. The advancements in organoid technology would lead to more accurate and diverse disease models, opening new avenues for breakthroughs in understanding and treating complex diseases.

Regional Insights

In the Americas region, specifically the U.S. and Canada are focusing on organoid research, emphasized by substantial investments from both public and private sectors in biotechnology and a highly established healthcare and research sector. Consumer need is largely driven by the healthcare industry's pursuit of precision medicine and efficient drug testing platforms. The U.S. Patent and Trademark Office has witnessed a notable surge in patents related to organoid technology, reflecting a vibrant R&D landscape. APAC is rapidly emerging as a significant landscape for organoid research, fueled by substantial government investment and a strategic focus on biotechnology for facilitating national development. Japan's commitment to regenerative medicine, backed by supportive regulatory frameworks and significant funding, drives its human organoids market. Japanese consumers exhibit strong support for innovative healthcare solutions, reflecting proactive organoid adoption in drug development and personalized medicine. Increased government and private funding are essential to harness the full potential of organoids in addressing the region's unique healthcare challenges. The European Union's robust regulatory environment and strong support for research have fostered a conducive environment for organoid development. EU-wide initiatives aim to integrate organoids into pharmaceutical research and clinical practices, addressing consumer needs for innovative and ethical testing methods. The Horizon 2020 program reflects Europe's commitment to advancing organoid technology. The Middle East shows growth in the human organoids market, with investments in biomedical research and education.

Market Insights

Market Dynamics

  • The market dynamics represent an ever-changing landscape of the Human Organoids Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers

  • High need for developing alternatives for animal testing models
  • Rising focus toward improving disease models and drug discovery

Market Restraints

  • Limited availability of skilled workforce

Market Opportunities

  • Significant increase in research funding and capital investments for the development of human organoids
  • Potential application of human organoids for biocomputing

Market Challenges

  • Issues related to current organoid technology

Market Segmentation Analysis

  • Product: Emerging crucial role of liver organoids in pharmacology and toxicology studies
  • Application: Increasing adoption of human organoids in drug toxicity and efficacy testing to improve patient care and safety
  • Usability: Increasing usage of customizable products that allow researchers to tailor organoid cultures to their specific needs
  • End-User: Rising need for human organoids across academic & research institutions for identifying novel drug targets and understanding disease progression

Industry Insights

  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Human Organoids Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Human Organoids Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Transforming Disease Research and Drug Discovery with Sinai Health's USD 10 Million Investment in Lab-Grown Organoids

Sinai Health received a significant USD 10 million funding injection for the development and cultivation of laboratory-grown organoids. This substantial investment emphasizes a pioneering approach to revolutionizing disease research and drug discovery techniques. Organoids, which are three-dimensional microstructures that simulate real human organs, are at the forefront of enabling more accurate and ethical testing environments, as they closely mimic the complex biological functions of their in vivo counterparts. Sinai Health aims to spearhead advancements in understanding various diseases and expedite the development of novel therapeutics by incorporating these lab-grown models.

Partnership Advances Cardiac Safety Testing in Drug Development: ATCC and Tissue Dynamics Collaboration

ATCC and Tissue Dynamics announced revolutionizing cardiac safety testing in drug development by introducing workflow-friendly cardiac organoids-based kits in a landmark collaboration facilitated by a two-year grant from the Israel-U.S. Binational Industrial Research and Development Foundation (BIRD). This initiative combines Tissue Dynamics' groundbreaking work on a mature, self-paced, multi-chambered cardiac organoid model developed in partnership with the Hebrew University of Jerusalem with ATCC's exceptional expertise in cellular biology. The organoid model, which effectively mirrors critical elements of human cardiac physiology, has already demonstrated its potential by identifying drug-induced cardiotoxicity rapidly, an issue underlying one in four clinical trial failures.

Advancing Drug Safety with Human Liver Organoid Technology: CuSTOM and Danaher Corporation's Innovative Collaboration

The CuSTOM Accelerator Lab at Cincinnati Children entered a multi-year initiative in collaboration with Danaher Corporation's Beacons program to refine human liver organoid technology, enhancing preclinical medication testing to mitigate drug-induced liver injury risks in clinical trials. This collaboration aims to revolutionize drug safety evaluations by leveraging the capabilities of human organoid technology, potentially bypassing the once-mandatory animal testing phase as per the latest FDA regulatory adjustments.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Human Organoids Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Human Organoids Market, highlighting leading vendors and their innovative profiles. These include 3Dnamics Inc., AIVITA Biomedical, Inc., BICO Group AB, Bio-Techne Corporation, BioIVT LLC, BrainZell, Cannex Scientific, Inc., CN Bio Innovations Limited, Corning Incorporated, DefiniGEN Limited, F. Hoffmann-La Roche Ltd., HeartBeat.bio AG, Herophilus, HUB Organoids B.V., InSphero AG, Kirkstall Ltd., Merck KGaA, Miltenyi Biotec B.V. & CO. KG, Mimetas BV, Molecular Devices, LLC by Danaher Corporation, Neurxstem Inc., Organovo Holdings Inc., Pandorum Technologies Pvt. Ltd., PerkinElmer, Inc., PRIMACYT Cell Culture Technology GmbH, Rumi Scientific, Inc., STEMCELL Technologies Canada Inc., SUN bioscience SA., Takara Holdings Inc., Thermo Fisher Scientific Inc., and ZenBio, Inc..

Market Segmentation & Coverage

This research report categorizes the Human Organoids Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product

  • Colorectal
  • Heart
  • Kidney
  • Liver
  • Pancreas

Usability

  • Customizable Products
  • Ready to Use Products

Application

  • Developmental Biology
  • Disease Pathology
  • Drug Toxicity & Efficacy Testing
  • Personalized Medicine
  • Regenerative Medicine

End-User

  • Academic & Research Institutes
  • Clinical Research Organizations
  • Pharmaceutical & Biotechnology Companies

Region

Americas

  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
  • California
  • Florida
  • Illinois
  • Maryland
  • Massachusetts
  • New York
  • Ohio
  • Pennsylvania
  • Texas

Asia-Pacific

  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
  • Vietnam

Europe, Middle East & Africa

  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. High need for developing alternatives for animal testing models
5.1.1.2. Rising focus toward improving disease models and drug discovery
5.1.2. Restraints
5.1.2.1. Limited availability of skilled workforce
5.1.3. Opportunities
5.1.3.1. Significant increase in research funding and capital investments for the development of human organoids
5.1.3.2. Potential application of human organoids for biocomputing
5.1.4. Challenges
5.1.4.1. Issues related to current organoid technology
5.2. Market Segmentation Analysis
5.2.1. Product: Emerging crucial role of liver organoids in pharmacology and toxicology studies
5.2.2. Application: Increasing adoption of human organoids in drug toxicity and efficacy testing to improve patient care and safety
5.2.3. Usability: Increasing usage of customizable products that allow researchers to tailor organoid cultures to their specific needs
5.2.4. End-User: Rising need for human organoids across academic & research institutions for identifying novel drug targets and understanding disease progression
5.3. Market Trend Analysis
5.3.1. Rising research & development activities for the development of human organoids in the Americas
5.3.2. Rising investment in biotechnology sector coupled with supportive regulatory environment in APAC region
5.3.3. Extensive R&D for drug discovery and tissue engineering in EMEA with establishment of new organoid development facilities
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework Analysis
6. Human Organoids Market, by Product
6.1. Introduction
6.2. Colorectal
6.3. Heart
6.4. Kidney
6.5. Liver
6.6. Pancreas
7. Human Organoids Market, by Usability
7.1. Introduction
7.2. Customizable Products
7.3. Ready to Use Products
8. Human Organoids Market, by Application
8.1. Introduction
8.2. Developmental Biology
8.3. Disease Pathology
8.4. Drug Toxicity & Efficacy Testing
8.5. Personalized Medicine
8.6. Regenerative Medicine
9. Human Organoids Market, by End-User
9.1. Introduction
9.2. Academic & Research Institutes
9.3. Clinical Research Organizations
9.4. Pharmaceutical & Biotechnology Companies
10. Americas Human Organoids Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Human Organoids Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Human Organoids Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. Transforming Disease Research and Drug Discovery with Sinai Health's USD 10 Million Investment in Lab-Grown Organoids
13.3.2. Partnership Advances Cardiac Safety Testing in Drug Development: ATCC and Tissue Dynamics Collaboration
13.3.3. Advancing Drug Safety with Human Liver Organoid Technology: CuSTOM and Danaher Corporation's Innovative Collaboration
13.3.4. Revolutionary Advancements in Neurodegenerative Disease Modeling Through Stem Cell-Derived Brain Organoids
13.3.5. Advancing Precision Medicine with Launch of a State-of-the-Art Organoid Facility for Next-Generation Disease Modeling
13.3.6. Roche's Revolutionary Launch: The Institute of Human Biology to Propel Medical Research with Organoid Technology
13.3.7. Roche Launches Institute of Human Biology in Basel to Revolutionize Drug Discovery with Organoid and Human Model System Research
13.3.8. New Frontiers by National Science Foundation's Directorate for Engineering: From Organoid Intelligence to Tailored Learning
13.3.9. Molecular Devices Partners with HUB Organoids to Advance 3D Biology Technologies
13.3.10. Innovating Drug Discovery: Molecular Devices and HUB Organoids Forge Strategic Partnership
14. Competitive Portfolio
14.1. Key Company Profiles
14.2. Key Product Portfolio
List of Figures
FIGURE 1. HUMAN ORGANOIDS MARKET RESEARCH PROCESS
FIGURE 2. HUMAN ORGANOIDS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL HUMAN ORGANOIDS MARKET SIZE, 2018-2030 (USD THOUSAND)
FIGURE 4. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD THOUSAND)
FIGURE 6. HUMAN ORGANOIDS MARKET DYNAMICS
FIGURE 7. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD THOUSAND)
FIGURE 9. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2023 VS 2030 (%)
FIGURE 10. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2023 VS 2024 VS 2030 (USD THOUSAND)
FIGURE 11. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 12. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD THOUSAND)
FIGURE 13. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 14. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD THOUSAND)
FIGURE 15. AMERICAS HUMAN ORGANOIDS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS HUMAN ORGANOIDS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
FIGURE 17. UNITED STATES HUMAN ORGANOIDS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES HUMAN ORGANOIDS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD THOUSAND)
FIGURE 19. ASIA-PACIFIC HUMAN ORGANOIDS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC HUMAN ORGANOIDS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA HUMAN ORGANOIDS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA HUMAN ORGANOIDS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
FIGURE 23. HUMAN ORGANOIDS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 24. HUMAN ORGANOIDS MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. HUMAN ORGANOIDS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL HUMAN ORGANOIDS MARKET SIZE, 2018-2023 (USD THOUSAND)
TABLE 4. GLOBAL HUMAN ORGANOIDS MARKET SIZE, 2024-2030 (USD THOUSAND)
TABLE 5. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY REGION, 2018-2023 (USD THOUSAND)
TABLE 6. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY REGION, 2024-2030 (USD THOUSAND)
TABLE 7. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 8. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 9. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY COLORECTAL, BY REGION, 2018-2023 (USD THOUSAND)
TABLE 10. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY COLORECTAL, BY REGION, 2024-2030 (USD THOUSAND)
TABLE 11. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY HEART, BY REGION, 2018-2023 (USD THOUSAND)
TABLE 12. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY HEART, BY REGION, 2024-2030 (USD THOUSAND)
TABLE 13. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY KIDNEY, BY REGION, 2018-2023 (USD THOUSAND)
TABLE 14. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY KIDNEY, BY REGION, 2024-2030 (USD THOUSAND)
TABLE 15. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY LIVER, BY REGION, 2018-2023 (USD THOUSAND)
TABLE 16. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY LIVER, BY REGION, 2024-2030 (USD THOUSAND)
TABLE 17. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY PANCREAS, BY REGION, 2018-2023 (USD THOUSAND)
TABLE 18. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY PANCREAS, BY REGION, 2024-2030 (USD THOUSAND)
TABLE 19. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2023 (USD THOUSAND)
TABLE 20. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2024-2030 (USD THOUSAND)
TABLE 21. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY CUSTOMIZABLE PRODUCTS, BY REGION, 2018-2023 (USD THOUSAND)
TABLE 22. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY CUSTOMIZABLE PRODUCTS, BY REGION, 2024-2030 (USD THOUSAND)
TABLE 23. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY READY TO USE PRODUCTS, BY REGION, 2018-2023 (USD THOUSAND)
TABLE 24. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY READY TO USE PRODUCTS, BY REGION, 2024-2030 (USD THOUSAND)
TABLE 25. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
TABLE 26. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
TABLE 27. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY DEVELOPMENTAL BIOLOGY, BY REGION, 2018-2023 (USD THOUSAND)
TABLE 28. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY DEVELOPMENTAL BIOLOGY, BY REGION, 2024-2030 (USD THOUSAND)
TABLE 29. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY DISEASE PATHOLOGY, BY REGION, 2018-2023 (USD THOUSAND)
TABLE 30. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY DISEASE PATHOLOGY, BY REGION, 2024-2030 (USD THOUSAND)
TABLE 31. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY DRUG TOXICITY & EFFICACY TESTING, BY REGION, 2018-2023 (USD THOUSAND)
TABLE 32. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY DRUG TOXICITY & EFFICACY TESTING, BY REGION, 2024-2030 (USD THOUSAND)
TABLE 33. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2018-2023 (USD THOUSAND)
TABLE 34. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2024-2030 (USD THOUSAND)
TABLE 35. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY REGENERATIVE MEDICINE, BY REGION, 2018-2023 (USD THOUSAND)
TABLE 36. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY REGENERATIVE MEDICINE, BY REGION, 2024-2030 (USD THOUSAND)
TABLE 37. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 38. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 39. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD THOUSAND)
TABLE 40. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD THOUSAND)
TABLE 41. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATIONS, BY REGION, 2018-2023 (USD THOUSAND)
TABLE 42. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATIONS, BY REGION, 2024-2030 (USD THOUSAND)
TABLE 43. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2023 (USD THOUSAND)
TABLE 44. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2030 (USD THOUSAND)
TABLE 45. AMERICAS HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 46. AMERICAS HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 47. AMERICAS HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2023 (USD THOUSAND)
TABLE 48. AMERICAS HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2024-2030 (USD THOUSAND)
TABLE 49. AMERICAS HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
TABLE 50. AMERICAS HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
TABLE 51. AMERICAS HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 52. AMERICAS HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 53. AMERICAS HUMAN ORGANOIDS MARKET SIZE, BY COUNTRY, 2018-2023 (USD THOUSAND)
TABLE 54. AMERICAS HUMAN ORGANOIDS MARKET SIZE, BY COUNTRY, 2024-2030 (USD THOUSAND)
TABLE 55. ARGENTINA HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 56. ARGENTINA HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 57. ARGENTINA HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2023 (USD THOUSAND)
TABLE 58. ARGENTINA HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2024-2030 (USD THOUSAND)
TABLE 59. ARGENTINA HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
TABLE 60. ARGENTINA HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
TABLE 61. ARGENTINA HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 62. ARGENTINA HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 63. BRAZIL HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 64. BRAZIL HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 65. BRAZIL HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2023 (USD THOUSAND)
TABLE 66. BRAZIL HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2024-2030 (USD THOUSAND)
TABLE 67. BRAZIL HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
TABLE 68. BRAZIL HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
TABLE 69. BRAZIL HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 70. BRAZIL HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 71. CANADA HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 72. CANADA HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 73. CANADA HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2023 (USD THOUSAND)
TABLE 74. CANADA HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2024-2030 (USD THOUSAND)
TABLE 75. CANADA HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
TABLE 76. CANADA HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
TABLE 77. CANADA HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 78. CANADA HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 79. MEXICO HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 80. MEXICO HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 81. MEXICO HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2023 (USD THOUSAND)
TABLE 82. MEXICO HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2024-2030 (USD THOUSAND)
TABLE 83. MEXICO HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
TABLE 84. MEXICO HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
TABLE 85. MEXICO HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 86. MEXICO HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 87. UNITED STATES HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 88. UNITED STATES HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 89. UNITED STATES HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2023 (USD THOUSAND)
TABLE 90. UNITED STATES HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2024-2030 (USD THOUSAND)
TABLE 91. UNITED STATES HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
TABLE 92. UNITED STATES HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
TABLE 93. UNITED STATES HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 94. UNITED STATES HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 95. UNITED STATES HUMAN ORGANOIDS MARKET SIZE, BY STATE, 2018-2023 (USD THOUSAND)
TABLE 96. UNITED STATES HUMAN ORGANOIDS MARKET SIZE, BY STATE, 2024-2030 (USD THOUSAND)
TABLE 97. ASIA-PACIFIC HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 98. ASIA-PACIFIC HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 99. ASIA-PACIFIC HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2023 (USD THOUSAND)
TABLE 100. ASIA-PACIFIC HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2024-2030 (USD THOUSAND)
TABLE 101. ASIA-PACIFIC HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
TABLE 102. ASIA-PACIFIC HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
TABLE 103. ASIA-PACIFIC HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 104. ASIA-PACIFIC HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 105. ASIA-PACIFIC HUMAN ORGANOIDS MARKET SIZE, BY COUNTRY, 2018-2023 (USD THOUSAND)
TABLE 106. ASIA-PACIFIC HUMAN ORGANOIDS MARKET SIZE, BY COUNTRY, 2024-2030 (USD THOUSAND)
TABLE 107. AUSTRALIA HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 108. AUSTRALIA HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 109. AUSTRALIA HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2023 (USD THOUSAND)
TABLE 110. AUSTRALIA HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2024-2030 (USD THOUSAND)
TABLE 111. AUSTRALIA HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
TABLE 112. AUSTRALIA HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
TABLE 113. AUSTRALIA HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 114. AUSTRALIA HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 115. CHINA HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 116. CHINA HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 117. CHINA HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2023 (USD THOUSAND)
TABLE 118. CHINA HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2024-2030 (USD THOUSAND)
TABLE 119. CHINA HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
TABLE 120. CHINA HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
TABLE 121. CHINA HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 122. CHINA HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 123. INDIA HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 124. INDIA HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 125. INDIA HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2023 (USD THOUSAND)
TABLE 126. INDIA HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2024-2030 (USD THOUSAND)
TABLE 127. INDIA HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
TABLE 128. INDIA HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
TABLE 129. INDIA HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 130. INDIA HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 131. INDONESIA HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 132. INDONESIA HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 133. INDONESIA HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2023 (USD THOUSAND)
TABLE 134. INDONESIA HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2024-2030 (USD THOUSAND)
TABLE 135. INDONESIA HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
TABLE 136. INDONESIA HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
TABLE 137. INDONESIA HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 138. INDONESIA HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 139. JAPAN HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 140. JAPAN HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 141. JAPAN HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2023 (USD THOUSAND)
TABLE 142. JAPAN HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2024-2030 (USD THOUSAND)
TABLE 143. JAPAN HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
TABLE 144. JAPAN HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
TABLE 145. JAPAN HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 146. JAPAN HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 147. MALAYSIA HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 148. MALAYSIA HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 149. MALAYSIA HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2023 (USD THOUSAND)
TABLE 150. MALAYSIA HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2024-2030 (USD THOUSAND)
TABLE 151. MALAYSIA HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
TABLE 152. MALAYSIA HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
TABLE 153. MALAYSIA HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 154. MALAYSIA HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 155. PHILIPPINES HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 156. PHILIPPINES HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 157. PHILIPPINES HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2023 (USD THOUSAND)
TABLE 158. PHILIPPINES HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2024-2030 (USD THOUSAND)
TABLE 159. PHILIPPINES HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
TABLE 160. PHILIPPINES HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
TABLE 161. PHILIPPINES HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 162. PHILIPPINES HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 163. SINGAPORE HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 164. SINGAPORE HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 165. SINGAPORE HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2023 (USD THOUSAND)
TABLE 166. SINGAPORE HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2024-2030 (USD THOUSAND)
TABLE 167. SINGAPORE HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
TABLE 168. SINGAPORE HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
TABLE 169. SINGAPORE HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 170. SINGAPORE HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 171. SOUTH KOREA HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 172. SOUTH KOREA HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 173. SOUTH KOREA HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2023 (USD THOUSAND)
TABLE 174. SOUTH KOREA HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2024-2030 (USD THOUSAND)
TABLE 175. SOUTH KOREA HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
TABLE 176. SOUTH KOREA HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
TABLE 177. SOUTH KOREA HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 178. SOUTH KOREA HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 179. TAIWAN HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 180. TAIWAN HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 181. TAIWAN HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2023 (USD THOUSAND)
TABLE 182. TAIWAN HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2024-2030 (USD THOUSAND)
TABLE 183. TAIWAN HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
TABLE 184. TAIWAN HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
TABLE 185. TAIWAN HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 186. TAIWAN HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 187. THAILAND HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 188. THAILAND HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 189. THAILAND HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2023 (USD THOUSAND)
TABLE 190. THAILAND HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2024-2030 (USD THOUSAND)
TABLE 191. THAILAND HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
TABLE 192. THAILAND HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
TABLE 193. THAILAND HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 194. THAILAND HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 195. VIETNAM HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 196. VIETNAM HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 197. VIETNAM HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2023 (USD THOUSAND)
TABLE 198. VIETNAM HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2024-2030 (USD THOUSAND)
TABLE 199. VIETNAM HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
TABLE 200. VIETNAM HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
TABLE 201. VIETNAM HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 202. VIETNAM HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2023 (USD THOUSAND)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2024-2030 (USD THOUSAND)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA HUMAN ORGANOIDS MARKET SIZE, BY COUNTRY, 2018-2023 (USD THOUSAND)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA HUMAN ORGANOIDS MARKET SIZE, BY COUNTRY, 2024-2030 (USD THOUSAND)
TABLE 213. DENMARK HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 214. DENMARK HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 215. DENMARK HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2023 (USD THOUSAND)
TABLE 216. DENMARK HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2024-2030 (USD THOUSAND)
TABLE 217. DENMARK HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
TABLE 218. DENMARK HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
TABLE 219. DENMARK HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 220. DENMARK HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 221. EGYPT HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 222. EGYPT HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 223. EGYPT HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2023 (USD THOUSAND)
TABLE 224. EGYPT HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2024-2030 (USD THOUSAND)
TABLE 225. EGYPT HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
TABLE 226. EGYPT HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
TABLE 227. EGYPT HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 228. EGYPT HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 229. FINLAND HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 230. FINLAND HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 231. FINLAND HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2023 (USD THOUSAND)
TABLE 232. FINLAND HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2024-2030 (USD THOUSAND)
TABLE 233. FINLAND HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
TABLE 234. FINLAND HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
TABLE 235. FINLAND HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 236. FINLAND HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 237. FRANCE HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 238. FRANCE HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 239. FRANCE HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2023 (USD THOUSAND)
TABLE 240. FRANCE HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2024-2030 (USD THOUSAND)
TABLE 241. FRANCE HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
TABLE 242. FRANCE HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
TABLE 243. FRANCE HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 244. FRANCE HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 245. GERMANY HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 246. GERMANY HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 247. GERMANY HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2023 (USD THOUSAND)
TABLE 248. GERMANY HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2024-2030 (USD THOUSAND)
TABLE 249. GERMANY HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
TABLE 250. GERMANY HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
TABLE 251. GERMANY HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 252. GERMANY HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 253. ISRAEL HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 254. ISRAEL HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 255. ISRAEL HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2023 (USD THOUSAND)
TABLE 256. ISRAEL HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2024-2030 (USD THOUSAND)
TABLE 257. ISRAEL HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
TABLE 258. ISRAEL HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
TABLE 259. ISRAEL HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 260. ISRAEL HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 261. ITALY HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 262. ITALY HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 263. ITALY HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2023 (USD THOUSAND)
TABLE 264. ITALY HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2024-2030 (USD THOUSAND)
TABLE 265. ITALY HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
TABLE 266. ITALY HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
TABLE 267. ITALY HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 268. ITALY HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 269. NETHERLANDS HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 270. NETHERLANDS HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 271. NETHERLANDS HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2023 (USD THOUSAND)
TABLE 272. NETHERLANDS HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2024-2030 (USD THOUSAND)
TABLE 273. NETHERLANDS HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
TABLE 274. NETHERLANDS HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
TABLE 275. NETHERLANDS HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 276. NETHERLANDS HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 277. NIGERIA HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 278. NIGERIA HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 279. NIGERIA HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2023 (USD THOUSAND)
TABLE 280. NIGERIA HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2024-2030 (USD THOUSAND)
TABLE 281. NIGERIA HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
TABLE 282. NIGERIA HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
TABLE 283. NIGERIA HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 284. NIGERIA HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 285. NORWAY HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 286. NORWAY HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 287. NORWAY HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2023 (USD THOUSAND)
TABLE 288. NORWAY HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2024-2030 (USD THOUSAND)
TABLE 289. NORWAY HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
TABLE 290. NORWAY HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
TABLE 291. NORWAY HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 292. NORWAY HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 293. POLAND HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 294. POLAND HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 295. POLAND HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2023 (USD THOUSAND)
TABLE 296. POLAND HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2024-2030 (USD THOUSAND)
TABLE 297. POLAND HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
TABLE 298. POLAND HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
TABLE 299. POLAND HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 300. POLAND HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 301. QATAR HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 302. QATAR HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 303. QATAR HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2023 (USD THOUSAND)
TABLE 304. QATAR HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2024-2030 (USD THOUSAND)
TABLE 305. QATAR HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
TABLE 306. QATAR HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
TABLE 307. QATAR HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 308. QATAR HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 309. RUSSIA HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 310. RUSSIA HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 311. RUSSIA HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2023 (USD THOUSAND)
TABLE 312. RUSSIA HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2024-2030 (USD THOUSAND)
TABLE 313. RUSSIA HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
TABLE 314. RUSSIA HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
TABLE 315. RUSSIA HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 316. RUSSIA HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 317. SAUDI ARABIA HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 318. SAUDI ARABIA HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 319. SAUDI ARABIA HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2023 (USD THOUSAND)
TABLE 320. SAUDI ARABIA HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2024-2030 (USD THOUSAND)
TABLE 321. SAUDI ARABIA HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
TABLE 322. SAUDI ARABIA HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
TABLE 323. SAUDI ARABIA HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 324. SAUDI ARABIA HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 325. SOUTH AFRICA HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 326. SOUTH AFRICA HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 327. SOUTH AFRICA HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2023 (USD THOUSAND)
TABLE 328. SOUTH AFRICA HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2024-2030 (USD THOUSAND)
TABLE 329. SOUTH AFRICA HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
TABLE 330. SOUTH AFRICA HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
TABLE 331. SOUTH AFRICA HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 332. SOUTH AFRICA HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 333. SPAIN HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 334. SPAIN HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 335. SPAIN HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2023 (USD THOUSAND)
TABLE 336. SPAIN HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2024-2030 (USD THOUSAND)
TABLE 337. SPAIN HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
TABLE 338. SPAIN HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
TABLE 339. SPAIN HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 340. SPAIN HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 341. SWEDEN HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 342. SWEDEN HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 343. SWEDEN HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2023 (USD THOUSAND)
TABLE 344. SWEDEN HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2024-2030 (USD THOUSAND)
TABLE 345. SWEDEN HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
TABLE 346. SWEDEN HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
TABLE 347. SWEDEN HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 348. SWEDEN HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 349. SWITZERLAND HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 350. SWITZERLAND HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 351. SWITZERLAND HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2023 (USD THOUSAND)
TABLE 352. SWITZERLAND HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2024-2030 (USD THOUSAND)
TABLE 353. SWITZERLAND HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
TABLE 354. SWITZERLAND HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
TABLE 355. SWITZERLAND HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 356. SWITZERLAND HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 357. TURKEY HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 358. TURKEY HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 359. TURKEY HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2023 (USD THOUSAND)
TABLE 360. TURKEY HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2024-2030 (USD THOUSAND)
TABLE 361. TURKEY HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2023 (USD THOUSAND)
TABLE 362. TURKEY HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2024-2030 (USD THOUSAND)
TABLE 363. TURKEY HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
TABLE 364. TURKEY HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
TABLE 365. UNITED ARAB EMIRATES HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2023 (USD THOUSAND)
TABLE 366. UNITED ARAB EMIRATES HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2024-2030 (USD THOUSAND)
TABLE 367. UNITED ARAB EMIRATES HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2023 (USD THOUSAND)
TABLE 368. UNITED ARAB EMIRATES HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2024-2030 (US

Companies Mentioned

  • 3Dnamics Inc.
  • AIVITA Biomedical, Inc.
  • BICO Group AB
  • Bio-Techne Corporation
  • BioIVT LLC
  • BrainZell
  • Cannex Scientific, Inc.
  • CN Bio Innovations Limited
  • Corning Incorporated
  • DefiniGEN Limited
  • F. Hoffmann-La Roche Ltd.
  • HeartBeat.bio AG
  • Herophilus
  • HUB Organoids B.V.
  • InSphero AG
  • Kirkstall Ltd.
  • Merck KGaA
  • Miltenyi Biotec B.V. & CO. KG
  • Mimetas BV
  • Molecular Devices, LLC by Danaher Corporation
  • Neurxstem Inc.
  • Organovo Holdings Inc.
  • Pandorum Technologies Pvt. Ltd.
  • PerkinElmer, Inc.
  • PRIMACYT Cell Culture Technology GmbH
  • Rumi Scientific, Inc.
  • STEMCELL Technologies Canada Inc.
  • SUN bioscience SA.
  • Takara Holdings Inc.
  • Thermo Fisher Scientific Inc.
  • ZenBio, Inc.

Methodology

Loading
LOADING...

Table Information